3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Leukemia
2
Vomiting
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Recurrence
1
PRETEXT I Hepatoblastoma
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Nausea
1
Lymphoma, Large-Cell, Anaplastic
1
Localized Extraskeletal Ewing Sarcoma
1
Liposarcoma
1
Leiomyosarcoma
1
Hypersensitivity
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Ganglioneuroblastoma
1
Fibrosarcoma
1
Extravasations of Anthracycline Anti-cancer Agents
1
Drug-Related Side Effects and Adverse Reactions
1
Dermatofibrosarcoma
1
Degradation of Top2b and Top2a in Human by Dexrazoxane
1
Central Nervous System Neoplasms
1
Interventions
fludarabine phosphate
15
Cyclophosphamide
13
Whole-Body Irradiation
12
Peripheral Blood Stem Cell Transplantation
12
Tacrolimus
10
Etoposide
10
Rituximab
8
Mycophenolic Acid
8
Methotrexate
6
Melphalan
6
Cyclosporine
6
Busulfan
6
Antilymphocyte Serum
6
Vorinostat
4
Sirolimus
4
Prednisone
4
Lenalidomide
4
Immunohistochemistry
4
Gene Expression Profiling
4
Carboplatin
4
Vincristine
3
Microarray Analysis
3
Gemcitabine
3
Everolimus
3
Doxorubicin
3
Dexamethasone
3
Brentuximab Vedotin
3
Alemtuzumab
3
10-propargyl-10-deazaaminopterin
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoblastic Lymphadenopathy
×
Dexrazoxane
×
Clear all
No trials found.